ESR1 and breast carcinoma: Combined with its fast and high-yielding radiosynthesis (AY = 25% after 77 min), 18F-TA-Glyco-EE was therefore assumed to be a promising 18F-labeled ER ligand for the PET imaging of ER+ breast cancer and was further evaluated in vivo.